M3 Wake Research Integrated Site Network is an owned group of premier clinical research sites that is a unique and innovative resource for Phase I - IV clinical trials. We offer Principal Investigators with a wide variety of therapeutic expertise who conduct studies that are suitable for a demographically and geographically diverse pool of qualified individuals.
The Wake Research sites encompass 11 locations in 6 states across the Western, Southern and Southeastern United States with a database reaching nearly one million subjects. We offer partners centralized contract and regulatory support, and feature an in-house marketing and advertising team focused on quick-starts to enrollment.
Our board-certified physicians have completed more than 6,000 successful clinical trials. Clinical trials at our sites are completed on time and with accuracy. We consistently exceed sponsor expectations for integrity, subject enrollment, human protection and expeditious delivery of accurate evaluable data.